Puma Biotechnology, Inc. (PBYI) Ownership

$2.90

south_east
-$0.02 (-0.69%)
Day's range
$2.78
Day's range
$2.94

Puma Biotechnology, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 02/07/2025 3.82 M $11.66 M   -0.09% 7.80%
VANGUARD GROUP INC 02/11/2025 3.64 M $11.11 M   0.20% 7.43%
02/14/2025 2.45 M $12.02 M   100.00% 5.00%
ACADIAN ASSET MANAGEMENT LLC 02/11/2025 1.97 M $6.01 M   0.16% 4.02%
MILLENNIUM MANAGEMENT LLC 02/14/2025 1.89 M $5.78 M   -34.25% 3.86%
RENAISSANCE TECHNOLOGIES LLC 02/13/2025 1.76 M $5.35 M   -0.95% 3.58%
EVERSEPT PARTNERS, LP 02/14/2025 996,102 $3.04 M   -22.98% 2.03%
AMERICAN CENTURY COMPANIES INC 02/11/2025 948,376 $2.89 M   8.44% 1.94%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 919,435 $2.80 M   0.23% 1.88%
DIMENSIONAL FUND ADVISORS LP 02/13/2025 863,760 $2.64 M   24.68% 1.76%
KENNEDY CAPITAL MANAGEMENT LLC 02/13/2025 809,375 $2.47 M   36.48% 1.65%
STATE STREET CORP 02/14/2025 609,942 $1.86 M   1.40% 1.24%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 02/10/2025 487,368 $1.49 M   32.27% 0.99%
GLOBEFLEX CAPITAL L P 02/10/2025 452,606 $1.38 M   0.00% 0.92%
BANK OF NEW YORK MELLON CORP 02/04/2025 331,853 $1.01 M   19.50% 0.68%
NORTHERN TRUST CORP 02/14/2025 325,417 $992,522   2.42% 0.66%
GOLDMAN SACHS GROUP INC 02/11/2025 314,097 $957,996   2.74% 0.64%
SEI INVESTMENTS CO 02/11/2025 311,661 $950,557   8.03% 0.64%
LOS ANGELES CAPITAL MANAGEMENT LLC 02/04/2025 285,679 $871,321   16.27% 0.58%
MORGAN STANLEY 02/14/2025 270,334 $824,520   -3.95% 0.55%
D. E. SHAW & CO., INC. 02/14/2025 222,608 $678,954   287.90% 0.45%
TANG CAPITAL MANAGEMENT LLC 02/14/2025 200,000 $610,000   0.00% 0.41%
TWO SIGMA ADVISERS, LP 02/14/2025 196,900 $600,545   22.30% 0.40%
QUBE RESEARCH & TECHNOLOGIES LTD 02/14/2025 188,124 $573,778   -7.88% 0.38%
TWO SIGMA INVESTMENTS, LP 02/14/2025 181,471 $553,487   266.20% 0.37%
PROSPERA FINANCIAL SERVICES INC 02/13/2025 177,895 $542,553   5.34% 0.36%
FEDERATED HERMES, INC. 02/13/2025 163,641 $499,105   2.16% 0.33%
CITADEL ADVISORS LLC 02/14/2025 159,425 $486,246   2,214.20% 0.33%
UBS GROUP AG 02/14/2025 155,571 $474,492   474.19% 0.32%
JPMORGAN CHASE & CO 02/12/2025 136,897 $417,535   182.30% 0.28%
FMR LLC 02/13/2025 131,850 $402,143   11.49% 0.27%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 117,666 $358,881   0.00% 0.24%
O'SHAUGHNESSY ASSET MANAGEMENT, LLC 02/12/2025 112,571 $343,342   99.70% 0.23%
GSA CAPITAL PARTNERS LLP 02/07/2025 108,523 $331,000   119.27% 0.22%
PRUDENTIAL FINANCIAL INC 02/11/2025 106,285 $324,169   5.77% 0.22%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 02/14/2025 105,200 $320,860   0.77% 0.21%
BARCLAYS PLC 02/13/2025 88,407 $270,000   13.31% 0.18%
MARSHALL WACE, LLP 02/13/2025 85,580 $261,019   100.00% 0.17%
ROYAL BANK OF CANADA 02/14/2025 82,882 $253,000   1,178.06% 0.17%
BANK OF AMERICA CORP /DE/ 02/14/2025 82,339 $251,134   103.06% 0.17%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 79,101 $241,258   41.45% 0.16%
MACKENZIE FINANCIAL CORP 02/20/2025 78,653 $239,892   100.00% 0.16%
SQUAREPOINT OPS LLC 02/14/2025 75,929 $231,583   -23.49% 0.15%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 75,103 $229,064   100.00% 0.15%
BNP PARIBAS ARBITRAGE, SNC 02/14/2025 74,301 $226,618   9.75% 0.15%
MACQUARIE GROUP LTD 02/14/2025 61,255 $187,000   0.00% 0.13%
02/13/2025 59,866 $182,591   100.00% 0.12%
XTX TOPCO LTD 02/13/2025 59,674 $182,006   126.18% 0.12%
PANAGORA ASSET MANAGEMENT INC 02/13/2025 58,849 $179,489   -42.32% 0.12%
LSV ASSET MANAGEMENT 02/13/2025 53,400 $163,000   75.66% 0.11%

Puma Biotechnology, Inc. institutional Ownership - FAQ's

During the previous two years, 165 institutional investors and hedge funds held shares of Puma Biotechnology, Inc.. The most heavily invested institutionals were:

BlackRock, Inc.: 3.82 M

VANGUARD GROUP INC: 3.64 M

ACADIAN ASSET MANAGEMENT LLC: 1.97 M

MILLENNIUM MANAGEMENT LLC: 1.89 M

RENAISSANCE TECHNOLOGIES LLC: 1.76 M

Eversept Partners, LP: 996,102

56.56% of Puma Biotechnology, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 35.95 M shares in the last 24 months. This purchase volume represents approximately $104.26 M in transactions.